Las miopatías en la atención primaria

References

1. Jackson CE, Barohn RJ. A pattern recognition approach to myopathy. Continuum (Minneap Minn). 2013;19(6 Muscle Disease):1674-1697.

2. Barohn RJ, Dimachkie MM, Jackson CE. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin. 2014;32(3):569-593, vii.

3. Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O'Brien K, Campbell WW. Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis. Muscle Nerve. 2012;45(3):356-362.

4. Neal RC, Ferdinand KC, Ycas J, Miller E. Relationship of ethnic origin, gender, and age to blood creatine kinase levels. Am J Med. 2009;122(1):73-78.

5. Mor A, Wortmann RL, Mitnick HJ, Pillinger MH. Drugs causing muscle disease. Rheum Dis Clin North Am. 2011;37(2):219-231, vi.

6. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289(13):1681- 1690.

7. Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. 2009;150(12):858-868.

8. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62(9):2757-2766.

9. Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3- methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63(3):713-721.

10. Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immunemediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41(2):185-190.